Time-to-reach Target Calprotectin Level in Newly Diagnosed Patients With Inflammatory Bowel Disease

OBJECTIVES: Treatment targets in inflammatory bowel disease (IBD) move away from controlling symptoms towards complete recovery of the intestinal mucosa. Currently, the most frequently used noninvasive surrogate marker of mucosal healing is a faecal calprotectin concentration in the target range. Th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Pediatr Gastroenterol Nutr
Main Authors: Haisma, Sjoukje-Marije, Verkade, Henkjan J., Scheenstra, Rene, van der Doef, Hubert P.J., Bodewes, Frank A.J.A., van Rheenen, Patrick F.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2019
Assuntos:
Original Articles: Gastroenterology: Inflammatory Bowel Disease
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6750145/
https://ncbi.nlm.nih.gov/pubmed/31365486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPG.0000000000002458
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados